PAPILLON COURSE on THYROID ULTRASOUND

Section 2 The nodular goiter

Part 6 The shape of the nodule

Manual

 

OPENING

 

Taller-than-wide shape (TWS) or nonparallel orientation (NPO) is regarded as the most specific sign among suspicious ultrasound (US) characteristics. On the other hand, the sensitivity of NPO is substantially lower than that of microcalcification or hypoechogenicity. This sign is relatively easy to define, the interobserver agreement is good. Although irregular borders also rely on the shape of the nodule, when we talk about the shape of a nodule, most authors consider only NPO and not irregular

borders.

Nevertheless, these two suspicious characteristics together with extrathyroidal extension rely on the infiltrative growth of papillary thyroid cancer (PTC). The diagnostic performance is worse in the event of medullary thyroid cancer (MTC), and this sign is useless in the event of follicular thyroid cancer (FTC).

DEFINITION AND POSSIBLE EXPLANATIONS OF NONPARALLEL ORIENTATION

TWS means that the antero-posterior diameter exceeds the width of the nodule measured in transverse scan.
Taller-than-long shape (TLS) means that the antero-posterior diameter is larger than the length of the nodule measured in longitudinal scan.

Both types of NPO are evaluated in the axial plane by comparing the height or depth ('tallness') and width or length of a nodule measured parallel and perpendicular to the ultrasound beam, respectively. NPO is usually evident on visual inspection and rarely requires formal measurements. Although authors are on different views whether an equal distance is included or not included, this has very limited importance in the everyday practice.

As will be presented later, the guidelines differ whether they include the TLS among NPO.

The widely accepted explanation of this finding indicates that the malignant nodules grow across the normal tissue plane in a centrifugal manner, while benign nodules do the same in a parallel fashion (1-3). The finding that TWS occurs more frequently in benign lesions on CT scan than on US, led to another reasonable explanation. Benign nodules are easier to compress than malignant and we compress them in the US while do not in the case for CT (4).

 

SOME CONCERNS ABAOUT THE NONPAPARALLEL ORIENTATION

Although regarding NPO, a 'yes' or 'no' answer is accepted by the guideline, in the reality there is a continuous spectrum of this ratio. An arbitrarily chosen value, i.e., a yes or no answer does not reflect the reality. Indeed, higher the ratio of width to depth more likely the lesion being papillary cancer. (This problem is very similar to that in the event of echogenicity of the nodule.) However, there is no point in deviating from this somewhat lazy approach. A qualitative approach (i.e. a ratio of depth and width) would very likely better reflect reality than the long-used quantitative one 'yes' or 'no'), but the time spent on measurement would hardly pay off. , if an experienced investigator
On the other hand , an experienced examiner gains an overall impression of the nodule, a shape difference close to the nonparallel also plays a role in this, so if we assign significance to a depth-to-width ratio of 1.05, we have also attach significance to a ratio of 0.95. Moreover, considering the
growing number of publications on the use of artificial intelligence in thyroid US, it is worth mentioning that the NPO and the echogenicity of the nodule are those two characteristics which are relatively easy to measure.

More important is the second one. As with all other suspicious characteristics, NPO is useful in the diagnosis of PTC and to a lesser extent in MTC while useless in FTC. We always should bear in mind that when guideline speak about the usefulness of suspicious characteristics for diagnosing thyroid cancers, they think mostly or only of PTC. Otherwise, they would be wrong. Unfortunately, reading the guidelines and scoring systems they do not always reveal this very important distinction.

The third issue is self-evident: there is no US characteristics which had both an ideal sensitivity and specificity, and this is also true for NPO.

 

NONPARALLEL ORIENTATION IN THE MOST FREQUENT TYPES OF THYROID MALIGNANCIES

A taller-than-wide shape is an insensitive but highly specific indicator of malignancy (5-7). The specificity of NPO is about 90% in most studies (8). Nonparallel orientation has the highest specificity among suspicious US characteristics. Remonti et al. found the highest specificities for absence of elasticity, microcalcifications, irregular margins, and a 'taller-than-wide' shape (86.2, 87.8, 83.1, and 96.6%, respectively) (9). In a study which assessed the risk of malignancy in 2,000 thyroid nodules (63.4% benign and 36.6% malignant) (10). The following odds ratios (OR) were observed for malignancy: deeply hypoechoic (OR, 6.8; a relevant finding not specifically considered in the 2014 meta-analysis), spiculated or microlobulated margins (OR, 5.9), microcalcifications (OR, 3.3), solid nodule (OR, 2.6), slightly hypoechoic (OR, 2.6), nonparallel (taller than wide) growth (OR, 2.3), and irregular shape (OR, 1.3) (10). In the study of Campanella et al., the highest risk of malignancy was associated with a TWS (DOR of 10.2; 95% CI: 6.7-15.3), an absent halo sign (7.1; 95% CI: 3.7-13.7), microcalcifications (6.8; 95% CI: 4.7-9.7), and irregular margins (6.1; 95% CI: 3.1-12.0) (11). It is worth noticing the huge difference in OR in these large-scale studies, in the secondly

mentioned work (11), the 2.3 OR was the worst while in the firstly mentioned study (10), the 10.2 OR was the best among suspicious characteristics. Although the above-cited authors extend their conclusions to 'thyroid cancers', indeed these conclusions are relevant only in the event of PTC.

NPO is significantly more frequent in MTC compared with benign lesions, but the frequency is much lower than in PTC (12).

NPO has no relevance in the diagnosis of FTC.

Table 1 summarizes the occurrence of NPO in the 3 most common subtype of thyroid carcinomas (13-37). Similar to other characteristics, the NPO occurs significantly more frequently in papillary cancer compared with follicular carcinoma. The occurrence of NPO in MTC is between that of FTC and PTC but it is closer close to the latter. The broad range of the observed frequencies of NPO means that even in the event of a seemingly easy-to-judge characteristics, the interobserver agreement is far from the ideal.

Table 1 Occurrence of nonparallel orientation in the three most common subtypes of thyroid carcinomas.

Occurrence - range (%)

Occurrence - median (%)

Follicular carcinoma

0 - 26.1

4.1

Medullary carcinoma

2.9 - 46.6

28.9

Papillary carcinoma

9.6 - 70.5

36.4

Refs 13-37.

 

THE ROLE OF NONPARALLEL ORIENTATION IN VARIOUS TIRADS

TWS belongs to the most suspicious features in all TIRADS (38-42). The presence of TWS automatically groups the lesion among the most suspicious subgroup in the AACE and in the European TIRADS, while to classify a lesion showing TWS into the most suspicious category requires that the nodule should be hypoechoic nodules in the ATA and Korean TIRADS. Regarding the ACR TIRADS, the presence of TWS worth three points. Following the logic of this system, it means that such lesions should be categorized into category 4 or 5 depending on the presence of

other suspicious signs. (See Table 2.)

There is an important difference between the TIRADS. It affects the handling of nodules presenting TLS. Three TIRADS involve TLS among nonparallel orientation (40-42) while two do not (38-39).

It seems to be more justified to include TLS among NPO (43).

Table 2 The role of extrathyroidal extension in the most important TIRADS systems.

Type of TIRADS

Echogenicity of the nodule

Nonparallel orientation present*

AACE

Irrelevant

3

ACR

4 or 5

ATA

Non-hypoechoic

Non-classifiable

Hypoechoic

5

European

Irrelevant

5

Korean

Non-hypoechoic

4

 

Hypoechoic

5

* The ACR, the European and the Korean TIRADS classify taller-than-long shape as nonparallel orientation while the AACE and ATA TIRADS do not.

 

PATTERNS CAUSING DIFFERENTIAL DIAGNOSTIC PROBLEMS IN THE EVENT OF NONPARALLEL ORIENTATION

Compared with other suspicious characteristics, NPO is much less prone to interpretation difficulties. In the everyday practice we meet two types of deceptive patterns (see Table 3).

The first is caused by normal anatomical situation. The thyroid not infrequently presents itself NPO. Baek et. al found NPO in 15% of diffuse thyroid diseases (44). If the thyroid has taller-than-long-shape than the normal growth of a nodule simply follows the shape of the thyroid.

The second affects nodules located in the upper pole of the lobe. To a lesser extent, nodules located in the lower pole are also affected. The thyroid as a rotational ellipsoid normally narrows in its poles which hinders the usual extension of the nodule into the transverse direction.

We meet the third anatomical situation in nodules that form between the trachea and the carotid artery are much more difficult to grow sideways and therefore much more likely present taller-than-wide shape.

The second group of issues is caused by pathological conditions. The

sideway growth can be hindered by a neighboring nodule. This is particularly true for those lesions which are sandwiched between two other lesions. A coarse calcification has two different deceptive impacts. The sideway extension of a nodule can be hindered if there is a macrocalcification close to the lesion. The other issue arises in nodules presenting macrocalcifications. The dorsal acoustic shadow makes the depth deceptively larger. The next problem is caused by the thyroiditis. A suspicious sign can be interpreted only in the context of pathological nodules and not in discrete lesions of more active foci of thyroiditis. In contrast with other deceptive patterns, in the event of thyroiditis not the presence of nonparallel orientation is the matter, but the presence of pathological nodule. Nevertheless, the NPO of a lesion can be of help in distinguishing foci of thyroiditis from potentially malignant nodules (see case). The guidelines fail to mention that the nonparallel orientation has very limited if any role in dominantly cystic nodules. A relatively rapidly growing fluid frequently makes the orientation of the nodule irregular. In such cases, not the tumorous proliferation but the accumulation of cystic content is responsible to the NPO. So, dominantly cystic nodules are the exceptions, NPO has limited if any significance in such lesions.  

Table 3 Some differential diagnostic issues in the judgement of nonparallel orientation of thyroid nodules.

1. The influence of the normal anatomy of the thyroid

  • nonparallel orientation of a lobe
  • upper pole nodules
  • nodules between the trachea and the carotid artery

2. Influence of pathological conditions

  • influence of neighboring nodule or nodules
  • macrocalcifications
  • thyroiditis
  • dominantly cystic nodules and nonparallel orientation

If a nodule is in close proximity to another lesion or more importantly, it is sandwiched between two other nodules than this location has influence to the shape. The neighboring nodule or nodules can prevent the extension of the lesion into the usual direction, i.e. into the medial/lateral or into the lower/upper direction. This may cause nonpathological form on NPO.

As with all other US characteristics, we should not forget that we speak of pathological nodules. Therefore, suspicious characteristics including NPO have no relevance in those discrete lesions of Hashimoto's thyroiditis which are not pathological nodules.

   

References

  1. Kim EK, Park CS, Chung WY, Oh KK, Kim DI, Lee JT, Yoo HS. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol. 2002 178 687-91.
  2. Alexander EK, Marqusee E, Orcutt J, Benson CB, Frates MC, Doubilet PM, Cibas ES, Atri A. Thyroid nodule shape and prediction of malignancy. Thyroid. 2004 14 953-8.
  3. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995 196 123-34.
  4. Yoon SJ, Yoon DY, Chang SK, Seo YL, Yun EJ, Choi CS, Bae SH. "Taller-than-wide sign" of thyroid malignancy: comparison between ultrasound and CT. AJR Am J Roentgenol. 2010 194 420-4. 
  5. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, Jung HK, Choi JS, Kim BM, Kim EK. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011 260 892-9. 
  6. Na DG, Baek JH, Sung JY, Kim JH, Kim JK, Choi YJ, Seo H. Thyroid Imaging Reporting and Data System Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity. Thyroid. 2016 26 562-72. 
  7. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH; Thyroid Study Group, Korean Society of Neuro- and Head and Neck Radiology. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology. 2008 247 762-70.
  8. Lee MJ, Kim EK, Kwak JY, Kim MJ. Partially cystic thyroid nodules on ultrasound: probability of malignancy and sonographic differentiation. Thyroid. 2009 Apr;19(4):341-6.
  9. Remonti LR, Kramer CK, Leitão CB, Pinto LC, Gross JL. Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid. 2015 25 538-50.
  10. Kwak JY, Jung I, Baek JH, Baek SM, Choi N, Choi YJ, Jung SL, Kim EK, Kim JA, Kim JH, Kim KS, Lee JH, Lee JH, Moon HJ, Moon WJ, Park JS, Ryu JH, Shin JH, Son EJ, Sung JY, Na DG; Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology. Image reporting and characterization system for ultrasound features of thyroid nodules: multicentric Korean retrospective study. Korean J Radiol. 2013 14 110-7. 
  11. Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014 10 203-11.
  12. Kim SH, Kim BS, Jung SL, Lee JW, Yang PS, Kang BJ, Lim HW, Kim JY, Whang IY, Kwon HS, Jung CK. Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Korean J Radiol. 2009 10 101-5.
  13. Trimboli P, Ngu R, Royer B, Giovanella L, Bigorgne C, Simo R, Carroll P & Russ G.  A multicentre validation study for the EU-TIRADS using histological diagnosis as a gold standard.  Clinical Endocrinology 2019 91 340-347.
  14. Zhu J, Li X, Wei X, Yang X, Zhao J, Zhang S & Guo Z.  The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma.  Cancer Medicine 2019 8 3389-3400.
  15. Yun G, Kim YK, Choi SI & Kim JH. Medullary thyroid carcinoma: Application of Thyroid Imaging Reporting and Data System (TI-RADS) Classification.  Endocrine 2018 61 285-292.
  16. Park JW, Kim DW, Kim D, Baek JW, Lee YJ & Baek HJ. Korean Thyroid Imaging Reporting and Data System features of follicular thyroid adenoma and carcinoma: a single-center study.  Ultrasonography 2017 36 349-354.
  17. Yoon JH, Han K, Kim EK, Moon HJ & Kwak JY. Diagnosis and Management of Small Thyroid Nodules: A Comparative Study with Six Guidelines for Thyroid Nodules. Radiology  2017  283  560-569.
  18. 19. Jeon EJ, Jeong YJ, Park SH, Cho CH, Shon HS & Jung ED. Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer According to the Tumor Size.  Journal of Korean Medical Science 2016 31 397-402.
  19. Lee SH, Baek JS, Lee JY, Lim JA, Cho SY, Lee TH, Ku YH, Kim HI & Kim MJ. Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm.   Endocrine Pathology   2013 24 177-183.
  20. Seo HS, Lee DH, Park SH, Min HS & Na DG. Thyroid follicular neoplasms: can sonography distinguish between adenomas and carcinomas? Journal of Clinical Ultrasound 2009 37 493-500.
  21. Lai X, Jiang Y, ng, Zhang B, Liang Z, Jiang Y, Li J, Zhao R, Yang X & Zhang X. Preoperative sonographic features of follicular thyroid carcinoma predict biological behavior: A retrospective study. Medicine. 2018 97 12814.
  22. Zhang JZ & Hu B. Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma. Journal of ultrasound in medicine 2014 33 221-227.
  23. Kuo TC, Wu MH, Chen KY, Hsieh MS, Chen A & Chen CN. Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma. Asian Journal of Surgery 2020 43 339-346.
  24. Gulcelik NE, Gulcelik MA & Kuru B Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features.  Archives of Otolaryngology Head & Neck Surgery   2008  134 1312-1315.
  25. Jeh SK, Jung SL, Kim BS & Lee YS. Evaluating the degree of conformity of papillary carcinoma and follicular carcinoma to the reported ultrasonographic findings of malignant thyroid tumor. Korean Journal of Radiology 2007 8 192-197.
  26. Choi YJ, Yun JS & Kim DH. Clinical and ultrasound features of cytology diagnosed follicular neoplasm.  Endocrine Journal 2009 56 383-389.
  27. Song YS, Kim JH, Na DG, Min HS, Won JK, Yun TJ, Choi SH & Sohn CH. Ultrasonographic Differentiation Between Nodular Hyperplasia and Neoplastic Follicular-Patterned Lesions of the Thyroid Gland.  Ultrasound in Medicine & Biology   2016 42 1816-1824.
  28. Lee S, Shin JH, Han BK & Ko EY. Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria. American Journal of Roentgenology 2010 194 1090-1094. 
  29. Kim SH, Kim BS, Jung SL, Lee JW, Yang PS, Kang BJ, Lim HW, Kim JY, Whang IY, Kwon HS & Jung CK. Ultrasonographic findings of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Korean Journal of Radiology 2009 10 101-105.
  30. Cai S, Liu H, Li WB, Ouyang YS, Zhang B, Li P, Wang XL, Zhang XY, Li JC & Jiang YX. Ultrasonographic features of medullary thyroid carcinoma and their diagnostic values. Chinese Medical Journal 2010 123 3074-3078.
  31. Saller B, Moeller L, Görges R, Janssen OE & Mann K. Role of conventional ultrasound and color Doppler sonography in the diagnosis of medullary thyroid carcinoma. Experimental and Clinical Endocrinology & Diabetes 2002 110 403-407
  32. Cho KE, Gweon HM, Park AY, Yoo MR, Kim J, Youk JH, Park YM & Son EJ. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels. Asian Pacific Journal of Cancer Prevention 2016 17 3357-3362.
  33. Yoon JH, Kim EK, Hong SW, Kwak JY & Kim MJ. Sonographic features of the follicular variant of papillary thyroid carcinoma. Journal of Ultrasound in Medicine 2008 27 1431-1437.
  34. Hahn SY, Han BK, Ko EY, Shin JH, Ko ES. Ultrasound findings of papillary thyroid carcinoma originating in the isthmus: comparison with lobe-originating papillary thyroid carcinoma. American Journal of Roentgenology  2014  203  637-642.
  35. Salmaslioglu A, Erbil Y, Dural C, Issever H, Kapran Y, Ozarmagan S & Tezelman S. Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter. World Journal of Surgery  2008 32 1948-54.
  36. Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, Agosti B &  Rosei EA. Thyroid nodule shape suggests malignancy. European Journal of Endocrinology. 2006 155 27-31.
  37. Sharma A, Gabriel H, Nemcek AA, Nayar R, Du H & Nikolaidis P. Subcentimeter thyroid nodules: utility of sonographic characterization and ultrasound-guided needle biopsy. American Journal of Roentgenology  2011 197 1123-8.
  38. Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, Paschke R, Valcavi R, Vitti P & AACE/ACE/AME Task Force on Thyroid Nodules.  American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocrine Practice 2016 22 622-39.
  39. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM & Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016 26 1-133.
  40. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, Lim HK, Moon WJ, Na DG, Park JS, Choi YJ, Hahn SY, Jeon SJ, Jung SL, Kim DW, Kim EK, Kwak JY, Lee CY, Lee HJ, Lee JH, Lee JH, Lee KH, Park SW & Sung JY. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean Journal of Radiology 2016 17 370-395.
  41. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, Hammers LW, Hamper UM, Langer JE, Reading CC, Scoutt LM& Stavros AT.  ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. Journal of the American College of Radiology 2017 14 587-595.
  42. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R & Leenhardt L. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. European Thyroid Journal 2017 6 225-237.
  43. Moon HJ, Kwak JY, Kim EK, Kim MJ. A taller-than-wide shape in thyroid nodules in transverse and longitudinal ultrasonographic planes and the prediction of malignancy. Thyroid 2011 21 1249-53. 
  44. Baek HJ, Kim DW, Lee YJ, Ahn HS, Ryu JH. Comparison of Real-Time and Static Ultrasonography Diagnoses for Detecting Incidental Diffuse Thyroid Disease: A Multicenter Study. Ultrasound Q. 2019 35 233-239.

 

 

 

 

 

 

 

 

 

mask